Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008-16: findings from the Global Rotavirus Surveillance Network.

Aliabadi N, Antoni S, Mwenda JM, Weldegebriel G, Biey JNM, Cheikh D, Fahmy K, Teleb N, Ashmony HA, Ahmed H, Daniels DS, Videbaek D, Wasley A, Singh S, de Oliveira LH, Rey-Benito G, Sanwogou NJ, Wijesinghe PR, Liyanage JBL, Nyambat B, Grabovac V, Heffelfinger JD, Fox K, Paladin FJ, Nakamura T, Agócs M, Murray J, Cherian T, Yen C, Parashar UD, Serhan F, Tate JE, Cohen AL.

Lancet Glob Health. 2019 Jul;7(7):e893-e903. doi: 10.1016/S2214-109X(19)30207-4.

PMID:
31200889
2.

Rotavirus gastroenteritis surveillance in Azerbaijan, 2011-2016.

Mursalova N, Shugayev N, Suleymanova J, Daniels DS, Wasley A, Cohen AL, Aliabadi N.

Vaccine. 2018 Dec 14;36(51):7790-7793. doi: 10.1016/j.vaccine.2018.02.045. Epub 2018 May 18.

PMID:
29784471
3.

Interim Guidance for Interpretation of Zika Virus Antibody Test Results.

Rabe IB, Staples JE, Villanueva J, Hummel KB, Johnson JA, Rose L; MTS, Hills S, Wasley A, Fischer M, Powers AM.

MMWR Morb Mortal Wkly Rep. 2016 Jun 3;65(21):543-6. doi: 10.15585/mmwr.mm6521e1.

4.

Impact and Effectiveness of Monovalent Rotavirus Vaccine in Armenian Children.

Sahakyan G, Grigoryan S, Wasley A, Mosina L, Sargsyan S, Asoyan A, Gevorgyan Z, Kocharyan K, Avagyan T, Lopman B, Vanyan A, Khactatryan S, Parashar UD, Cortese MM.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S147-54. doi: 10.1093/cid/ciw045.

PMID:
27059349
5.

Impact of Rotavirus Vaccine Introduction and Vaccine Effectiveness in the Republic of Moldova.

Gheorghita S, Birca L, Donos A, Wasley A, Birca I, Cojocaru R, Melnick A, Ciobanu S, Mosina L, Cortese MM, Parashar UD, Lopman B.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S140-6. doi: 10.1093/cid/civ1209.

PMID:
27059348
6.

Global invasive bacterial vaccine-preventable diseases surveillance--2008-2014.

Murray J, Agócs M, Serhan F, Singh S, Deloria-Knoll M, O'Brien K, Mwenda JM, Mihigo R, Oliveira L, Teleb N, Ahmed H, Wasley A, Videbaek D, Wijesinghe P, Thapa AB, Fox K, Paladin FJ, Hajjeh R, Schwartz S, Van Beneden C, Hyde T, Broome C, Cherian T; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Dec 12;63(49):1159-62.

7.

Viral gastroenteritis in rotavirus negative hospitalized children <5 years of age from the independent states of the former Soviet Union.

Chhabra P, Samoilovich E, Yermalovich M, Chernyshova L, Gheorghita S, Cojocaru R, Shugayev N, Sahakyan G, Lashkarashvili M, Chubinidze M, Zakhashvili K, Videbaek D, Wasley A, Vinjé J.

Infect Genet Evol. 2014 Dec;28:283-8. doi: 10.1016/j.meegid.2014.10.013. Epub 2014 Oct 19.

PMID:
25460823
8.

Rotavirus genotypes in Belarus, 2008-2012.

Semeiko GV, Yermalovich MA, Poliakova N, Mijatovic-Rustempasic S, Kerin TK, Wasley A, Videbaek D, Gentsch JR, Bowen MD, Samoilovich EO.

Infect Genet Evol. 2014 Dec;28:480-5. doi: 10.1016/j.meegid.2014.09.007. Epub 2014 Sep 16.

9.

WHO global rotavirus surveillance network: a strategic review of the first 5 years, 2008-2012.

Agócs MM, Serhan F, Yen C, Mwenda JM, de Oliveira LH, Teleb N, Wasley A, Wijesinghe PR, Fox K, Tate JE, Gentsch JR, Parashar UD, Kang G; Department of Immunization, Vaccines, and Biologicals, World Health Organization (WHO), Geneva, Switzerland; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):634-7. Review.

10.

Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009.

Jorgensen P, Wasley A, Mereckiene J, Cotter S, Weber JT, Brown CS.

Vaccine. 2013 Aug 28;31(38):4060-2. doi: 10.1016/j.vaccine.2013.06.082. Epub 2013 Jul 8.

PMID:
23845820
11.

Correction: The Increasing Burden of Imported Chronic Hepatitis B - United States, 1974-2008.

Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA.

PLoS One. 2013 Mar 5;8(3). doi: 10.1371/annotation/7f73ed17-709e-4d7f-9aae-aab1f4a34985. eCollection 2013.

12.

Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe.

Mereckiene J, Cotter S, Weber JT, Nicoll A, D'Ancona F, Lopalco PL, Johansen K, Wasley AM, Jorgensen P, Lévy-Bruhl D, Giambi C, Stefanoff P, Dematte L, O'Flanagan D; VENICE project gatekeepers group.

Euro Surveill. 2012 Jan 26;17(4). pii: 20064.

13.

The increasing burden of imported chronic hepatitis B--United States, 1974-2008.

Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA.

PLoS One. 2011;6(12):e27717. doi: 10.1371/journal.pone.0027717. Epub 2011 Dec 7. Erratum in: PLoS One. 2013 Mar 5;8(3):.

14.

Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the National Health and Nutrition Examination Survey.

Klevens RM, Kruszon-Moran D, Wasley A, Gallagher K, McQuillan GM, Kuhnert W, Teshale EH, Drobeniuc J, Bell BP.

Public Health Rep. 2011 Jul-Aug;126(4):522-32.

15.

Estimating the number of births to hepatitis B virus-infected women in 22 states, 2006.

Din ES, Wasley A, Jacques-Carroll L, Sirotkin B, Wang S.

Pediatr Infect Dis J. 2011 Jul;30(7):575-9. doi: 10.1097/INF.0b013e31820cd65c.

PMID:
21266937
16.

The prevalence of hepatitis B virus infection in the United States in the era of vaccination.

Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G, Bell B.

J Infect Dis. 2010 Jul 15;202(2):192-201. doi: 10.1086/653622.

PMID:
20533878
17.

Surveillance for acute viral hepatitis - United States, 2007.

Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2009 May 22;58(3):1-27.

18.

Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994.

Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE.

J Infect Dis. 2009 Jul 1;200(1):48-56. doi: 10.1086/599319.

19.

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection.

Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, Neitzel SM, Ward JW; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 Sep 19;57(RR-8):1-20.

20.

Surveillance for acute viral hepatitis--United States, 2006.

Wasley A, Grytdal S, Gallagher K; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2008 Mar 21;57(2):1-24.

21.

Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002-2003.

Simard EP, Miller JT, George PA, Wasley A, Alter MJ, Bell BP, Finelli L.

Infect Control Hosp Epidemiol. 2007 Jul;28(7):783-90. Epub 2007 May 24.

PMID:
17564979
22.

Surveillance for acute viral hepatitis--United States, 2005.

Wasley A, Miller JT, Finelli L; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2007 Mar 16;56(3):1-24.

23.

Hepatitis A in the era of vaccination.

Wasley A, Fiore A, Bell BP.

Epidemiol Rev. 2006;28:101-11. Epub 2006 Jun 14. Review.

PMID:
16775039
24.

Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP.

MMWR Recomm Rep. 2006 May 19;55(RR-7):1-23.

25.

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ.

Ann Intern Med. 2006 May 16;144(10):705-14.

PMID:
16702586
26.

Trends in liver cancer, Sa Kaeo Province Thailand.

Amon JJ, Nedsuwan S, Chantra S, Bell BP, Dowell SF, Olsen SJ, Wasley A.

Asian Pac J Cancer Prev. 2005 Jul-Sep;6(3):382-6.

27.

Incidence of hepatitis A in the United States in the era of vaccination.

Wasley A, Samandari T, Bell BP.

JAMA. 2005 Jul 13;294(2):194-201.

PMID:
16014593
28.

SARS surveillance during emergency public health response, United States, March-July 2003.

Schrag SJ, Brooks JT, Van Beneden C, Parashar UD, Griffin PM, Anderson LJ, Bellini WJ, Benson RF, Erdman DD, Klimov A, Ksiazek TG, Peret TC, Talkington DF, Thacker WL, Tondella ML, Sampson JS, Hightower AW, Nordenberg DF, Plikaytis BD, Khan AS, Rosenstein NE, Treadwell TA, Whitney CG, Fiore AE, Durant TM, Perz JF, Wasley A, Feikin D, Herndon JL, Bower WA, Klibourn BW, Levy DA, Coronado VG, Buffington J, Dykewicz CA, Khabbaz RF, Chamberland ME.

Emerg Infect Dis. 2004 Feb;10(2):185-94.

29.

An investigation of unexplained infant deaths in houses contaminated with methyl parathion.

Wasley A, Lepine LA, Jenkins R, Rubin C.

Environ Health Perspect. 2002 Dec;110 Suppl 6:1053-6.

30.

Epidemiology of hepatitis C: geographic differences and temporal trends.

Wasley A, Alter MJ.

Semin Liver Dis. 2000;20(1):1-16. Review.

PMID:
10895428
31.
32.

Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum.

Wilson CM, Serrano AE, Wasley A, Bogenschutz MP, Shankar AH, Wirth DF.

Science. 1989 Jun 9;244(4909):1184-6.

PMID:
2658061
33.

Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists.

Altar CA, Boyar WC, Wasley A, Gerhardt SC, Liebman JM, Wood PL.

Naunyn Schmiedebergs Arch Pharmacol. 1988 Aug;338(2):162-8.

PMID:
2903451
34.

CGS 10746B: an atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses.

Altar CA, Wasley AM, Liebman J, Gerhardt S, Kim H, Welch JJ, Wood PL.

Life Sci. 1986 Aug 25;39(8):699-705.

PMID:
2874470
35.

Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain.

Altar CA, Wasley AM, Neale RF, Stone GA.

Brain Res Bull. 1986 Apr;16(4):517-25.

PMID:
2872945
36.

Autoradiographic localization and pharmacology of unique [3H]tryptamine binding sites in rat brain.

Altar CA, Wasley AM, Martin LL.

Neuroscience. 1986;17(1):263-73.

PMID:
3960312

Supplemental Content

Loading ...
Support Center